Outcomes following complete response to immune checkpoint inhibitors in endometrial cancer.

O'Connor RM, Chalif J, Gonzalez A, Glassman DC, Morton MA, Velasquez J, Abdeen CS, Cohn DE, Copeland LJ, Cosgrove CM, Haight P, Nagel CI, Neff R, Backes FJ, O'Malley DM, Chambers LM

Open source

DOI: 10.1016/j.ygyno.2026.07.006
Published: 2026 Aug
Container: Gynecologic oncology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ygyno.2026.07.006,
  title = {Outcomes following complete response to immune checkpoint inhibitors in endometrial cancer.},
  author = {O'Connor RM and Chalif J and Gonzalez A and Glassman DC and Morton MA and Velasquez J and Abdeen CS and Cohn DE and Copeland LJ and Cosgrove CM and Haight P and Nagel CI and Neff R and Backes FJ and O'Malley DM and Chambers LM},
  year = {2026},
  journal = {Gynecologic oncology},
  doi = {10.1016/j.ygyno.2026.07.006},
  url = {https://doi.org/10.1016/j.ygyno.2026.07.006}
}

RIS

TY  - JOUR
TI  - Outcomes following complete response to immune checkpoint inhibitors in endometrial cancer.
AU  - O'Connor RM
AU  - Chalif J
AU  - Gonzalez A
AU  - Glassman DC
AU  - Morton MA
AU  - Velasquez J
AU  - Abdeen CS
AU  - Cohn DE
AU  - Copeland LJ
AU  - Cosgrove CM
AU  - Haight P
AU  - Nagel CI
AU  - Neff R
AU  - Backes FJ
AU  - O'Malley DM
AU  - Chambers LM
PY  - 2026
JO  - Gynecologic oncology
DO  - 10.1016/j.ygyno.2026.07.006
UR  - https://doi.org/10.1016/j.ygyno.2026.07.006
ER  -

APA

RM, O., J, C., A, G., DC, G., MA, M., J, V., CS, A., DE, C., LJ, C., CM, C., P, H., CI, N., R, N., FJ, B., DM, O., & LM, C. (2026). Outcomes following complete response to immune checkpoint inhibitors in endometrial cancer.. Gynecologic oncology. https://doi.org/10.1016/j.ygyno.2026.07.006

Source records

pubmed · retrieved 2026-09-25T23:27:38.289Z